Legal status by country
Is Rilmenidine legal?
Written by Aaron CuhaReviewed Sep 2026
How Rilmenidine is classified in the United States, United Kingdom, Australia and Canada, side by side. Each country has its own page with a direct answer, the regulator's approval status and what the classification means in practice.
All four countries, side by side
| Attribute | United States · FDA | United Kingdom · MHRA | Australia · TGA | Canada · Health Canada |
|---|---|---|---|---|
| Status | Not approved | Not approved | Not approved | Not approved |
| Classification | Not approved in the United States | Not licensed in the United Kingdom | Availability varies by market | Availability varies by market |
| Note | No FDA marketing authorisation. It is a licensed antihypertensive in France and several other European markets, which is why longevity buyers source it from abroad. | No MHRA marketing authorisation. | We could not confirm a current Australian registration as of September 2026. Treat claims about local availability as unverified. | We could not confirm a current Canadian authorisation as of September 2026. |
US FDA status: Not approved in the United States. Rilmenidine is a Servier product licensed as an antihypertensive in France and several other European markets under the names Hyperium, Tenaxum, Albarel and Iterium.. Reviewed Sep 2026.
Related compounds
General information current as of Sep 2026, not legal advice. Classifications change; confirm with the regulator or a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships.